Canaccord raised the firm’s price target on Enovis to $71 from $65 and keeps a Buy rating on the shares. The firm updated its model following its Q3 call which raised expectations for the full year.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ENOV:
- Enovis named 2024 Top Pick, added to Conviction List at Needham
- Enovis Announces Business Segment Leadership Transition Plan
- Enovis president and COO Brady Shirley to retire at end of 1Q25
- Orthofix names Massimo Calafiore President and CEO
- Enovis to participate in the 6th Annual EverCore ISI HealthCONx Conference
